EIF2A and prion disease: The treatment of a mouse model of prion disease with this inhibitor induced a repression of protein synthesis associated with decreased levels of p-PERK, p-eIF2α, ATF4 and CHOP, showing the neuroprotective effect of GSK2606414 [158,167].